"Frontiers of Digital Healthcare Transformation" LINK-J & UC San Diego Life Science Symposium ＃6

Panel Discussion
Panelists:
Dr. Chris Longhurst
Dr Sekitani
Dr. Ratnesh Lal
Dr. Ogishima
Mr. Matsuba
Moderator:
Dr. Albert P. Pisano

Chris Longhurst, MD, MS
Chief Medical Officer & Chief Digital Officer, UC San Diego Health
Associate Dean, UC San Diego School of Medicine

Christopher Longhurst MD, MS, is the chief medical officer (CMO) and chief digital officer (CDO) at UC San Diego Health. This dual, complementary role provides leadership to medical staff, ensuring that standards and protocols are in place to provide the highest quality of care to patients. He also serves as an associate dean at the School of Medicine, overseeing and aligning our education and research missions within the clinical environment, and leading our journey to become a highly reliable, learning health system.As CMO,
Dr. Longhurst is responsible for maintaining excellence in clinical care, including regulatory, patient and clinician satisfaction, quality and safety, and medical affairs. He works alongside leaders at UC San Diego Health, the School of Medicine, and UC Health to improve care delivery and oversees UC San Diego Health’s reputation for delivering safe, innovative, patient-centered care.
Dr. Longhurst is passionate about implementing innovative digital solutions that help improve the patient experience. As the CDO, he leads UC San Diego Health’s technology strategy, overseeing initiatives that advance the infrastructure across UC San Diego and the UC Health system. In addition, Dr. Longhurst leads the clinical activities of the academic medical center, working alongside clinical leaders to guide the planning of quality, safety, and performance excellence of programs.

He is also a key faculty member in the Departments of Biomedical Informatics and Pediatrics in the UC San Diego School of Medicine, maintaining an active clinical practice as a newborn hospitalist and pursuing scholarship in care quality, patient safety, and health informatics.
Prior to his current role, Dr. Longhurst served as the chief information officer (2015-2021) and associate chief medical officer for quality and safety (2018-2021) at UC San Diego Health, where he provided leadership in key functional areas to continuously improve efforts around operations, reputation and care.

Before joining UC San Diego Health, Dr. Longhurst served as chief medical information officer for Stanford Children's Health. He led strategic efforts to improve children's health and provider workflow using information technology. He founded and led the nation's first accredited clinical informatics fellowship at Stanford, where he was a clinical professor of pediatrics and biomedical informatics. He also staffed the quality committee of Stanford's hospital board and facilitated national quality improvement collaborative work.
Dr. Longhurst completed his residency at Stanford University and earned his medical degree and MS in medical informatics from UC Davis. He holds a BS in molecular biology from Revelle College at UC San Diego. He is a board-certified pediatrician and clinical informaticist.

He is the author and co-author of many publications on using technology and data to improve quality of care. Dr. Longhurst is an elected fellow of the prestigious American College of Medical Informatics.

Ratnesh Lal, PhD
Professor of Bioengineering, Mechanical Engineering, Material Science & Engineering, UC San Diego Jacobs School of Engineering

Lal is a professor of Bioengineering, Mechanical Engineering, Material Science & Engineering, and Co-Director of Center for Excellence in Nanomedcine and Engineering at UC San Diego.
He received his MS and Masters of Philosophy in Physics and Biophysics from JNU in New Delhi and his Ph.D. in Neurobiology from the University of Alabama. After postdoctoral training at Caltech, he was a faculty member at the University of Chicago and the University of California at Santa Barbara. Before accepting his current position at UC San Diego, he was a professor and the director of the newly established Center of Nanomedicine at the University of Chicago.
He is a Fellow of AAAS (the American Association for Advancement of Science) and a Fellow of the American Institute of Medical and Biological Engineering (AIMBE). He was a visiting professor at the Chinese Academy of Sciences, Institute for Applied Physics, Shanghai. Before, he was the UTS Invited Professor in Sydney for the Bionanotechnology initiative and a New Zealand Government International Science Scholar.
Professor Lal is an Associate Editor of the Journal Nanomedicine: Nanotechnology, Biology, Medicine. He is the Chairman of Vessel ANI, Inc, Ampera Life, Inc and is on advisory board of RC Nano LLC and Be Green Packaging LLC. Professor Lal served on the NIH Nano study section.
In addition to seminal research publications in the field of nanomedicine, he holds several patents based upon AFM cantilever arrays, microfluidics, optoelectronics and nanotubes for medical diagnostics and medical nanodevices, nanoscale fluid behavior and new TIRF, FRET and related optical microscopy.

Soichi Ogishima　
Tohoku University

東北大学高等研究機構未来型医療創成センター 教授。東北大学東北メディカル・メガバンク機構 医療情報ICT部門 ゲノム医科学情報学分野/情報セキュリティ分野 教授。2000年東京大学工学部計数工学科卒業、東京医科歯科大学大学院修了（博士（医学））。同大学助手・助教、ハイデルベルク大学 定量システム生物学研究所(BIOQUANT) 客員研究員を経て、2012年5月より東北大学 東北メディカル・メガバンク機構 講師、准教授、2018年4月から現職。専門はバイオインフォマティクス、ゲノム医療情報学。日本バイオインフォマティクス学会 理事、情報計算化学生物(CBI)学会 執行部会員・評議員、日本オミックス医学会 理事、日本医療情報学会 国際委員会委員、日本メディカルAI学会 評議員。

Tsuyoshi Sekitani
SANKEN, Osaka University

Tsuyoshi Sekitani is a Professor in The Institute of Scientific and Industrial Research (SANKEN), Osaka University. He received his Ph.D. from the Department of Applied Physics, School of Engineering, at the University of Tokyo, Japan, in 2003. From 2003 to 2010, he was an Assistant Professor, and in 2011, he was an Associate Professor in the School of Engineering at the University of Tokyo. In 2014, he was made a Full Professor in The Institute of Scientific and Industrial Research at Osaka University. In 2017, he was awarded as the title of Osaka University Distinguished Professor. From 2019, he is playing a leading role in the research intensification of Osaka University as an Executive Assistant to the President of Osaka University.

He is a member of the Cabinet Office Expert Council of the Japanese Government, an executive board member of Science Council of Japan (SCJ), director of the Engineering Academy of Japan (EAJ), and chairperson of the Young Researcher Committee of EAJ. He is currently an Associate Editor of ACS Nano, the premier international journal in nanoscience and nanotechnology. He is also on the editorial board of Advanced Electronic Materials (Wily) and MRS Bulletin (Springer Nature). In addition, he is the founder and director of PGV Inc., a medical device company.

He was awarded as “Highly Cited Researchers” (The World’s Most Influential Scientific Minds) from Thomson Reuters in 2014, and from Clarivate Analytics in 2018, IEEE Paul Rappaport Award in 2009 and 2010, and SID Jan Rajchman Prize in 2023.

Takehito Matsuba
Citadel AI Inc. Chief Operating Officer

Previously, Takehito led the launch of Google Health’s Japan business and the first joint research project on AI-assisted breast cancer screening with a leading cancer hospital in Japan. Prior to Google, he worked with Mitsubishi Corporation where he led investments, M&A, and new business development in the healthcare industry, and served as Director of North American Healthcare Business in the Bay area. He obtained an MBA from MIT Sloan School of Management.